# Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit

> **NCT03168529** · PHASE4 · TERMINATED · sponsor: **Phillip Levy** · enrollment: 19 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03168529
- **Lead sponsor:** Phillip Levy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Lack of patient enrollment
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168529, "Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03168529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*